Clinical trial
Inhibition of Delta-protein Kinase C for the Reduction of Infarct Size in Acute Myocardial Infarction
NCT00785954 is registered in ClinicalTrials.gov with KAI Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhibition of Delta-protein Kinase C for the Reduction of Infarct Size in Acute Myocardial Infarction
- Lead sponsor
- KAI Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2008
- Completion date
- May 31, 2011
- Enrollment
- 1,180 (actual)
- Sites
- 126
Conditions
As the registry lists them; a condition with its own page is linked.